Omega Fund IV, L.P. - 10%+ Owner at Replimune Group, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Omega Fund IV, L.P. since 7/7/2023

Holdings reported by Omega Fund IV, L.P. for Replimune Group, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 4,763,380 $52 M $10.92 Mar 14, 2022 By Otello Stampacchia
Common Stock 4,673,380 $51 M $10.92 Mar 16, 2022 Direct
Non-Qualified Stock Options 16,500 Mar 14, 2022 By Otello Stampacchia Common Stock

Transactions reported by Omega Fund IV, L.P. for Replimune Group, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership